Psychopathological comorbidities in medication-overuse headache

A multicentre clinical study

P. Sarchielli, I. Corbelli, P. Messina, L. M. Cupini, G. Bernardi, G. Bono, V. Di Piero, B. Petolicchio, P. Livrea, M. P. Prudenzano, L. A. Pini, G. Sandrini, M. Allena, G. Tedeschi, A. Russo, S. Caproni, E. Beghi, P. Calabresi

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Background and purpose: In medication-overuse headache (MOH) patients, the presence of psychopathological disturbances may be a predictor of relapse and poor response to treatment. This multicentre study aimed to assess the occurrence of psychopathological disorders in MOH patients by comparing the incidence of psychopathological disturbances with episodic migraine (EM) patients and healthy controls (HC). Methods: The psychopathological assessment of patients and HC involved the administrations of the Beck Depression Inventory, the Beck Anxiety Inventory, the Modified Mini International Neuropsychiatric Interview (M-MINI), the Yale-Brown Obsessive Compulsive Scale (Y-BOCS) and the Leeds Dependence Questionnaire. Results: The MOH, EM and HC groups (88, 129 and 102 subjects, respectively) differed significantly from each other for the presence of moderate/severe anxiety, whereas mood disorder and depression were revealed in similar proportions for both MOH and EM patients. By stratifying the M-MINI questionnaire results according to the number of psychiatric disorders, it was found that MOH patients had a more complex profile of psychiatric comorbidity. Furthermore, clinically relevant obsessive-compulsive disturbances for abused drugs assessed by Y-BOCS appeared to be more represented in the MOH group, whilst the prevalence of this trait in the EM group was comparable to that of HC (12.5%, 0.8% and 0%, respectively). Conclusions: Our study indicates the multiple presence of psychopathological comorbidities in patients with MOH. In light of this, it is recommended that the assessment of the psychopathological profile be included in an evaluation of MOH patients, allowing the clinician to more rapidly start an appropriate behavioural treatment, which would greatly improve MOH management.

Original languageEnglish
Pages (from-to)85-91
Number of pages7
JournalEuropean Journal of Neurology
Volume23
Issue number1
DOIs
Publication statusE-pub ahead of print - Jul 31 2015

Fingerprint

Secondary Headache Disorders
Multicenter Studies
Comorbidity
Migraine Disorders
Psychiatry
Anxiety
Interviews
Depression
Clinical Studies
Equipment and Supplies
Mood Disorders

Keywords

  • Case-control studies
  • Headache
  • Medication-overuse headache
  • Migraine
  • Obsessive-compulsive disturbances
  • Psychiatric disorders

ASJC Scopus subject areas

  • Clinical Neurology
  • Neurology

Cite this

Psychopathological comorbidities in medication-overuse headache : A multicentre clinical study. / Sarchielli, P.; Corbelli, I.; Messina, P.; Cupini, L. M.; Bernardi, G.; Bono, G.; Di Piero, V.; Petolicchio, B.; Livrea, P.; Prudenzano, M. P.; Pini, L. A.; Sandrini, G.; Allena, M.; Tedeschi, G.; Russo, A.; Caproni, S.; Beghi, E.; Calabresi, P.

In: European Journal of Neurology, Vol. 23, No. 1, 31.07.2015, p. 85-91.

Research output: Contribution to journalArticle

Sarchielli, P, Corbelli, I, Messina, P, Cupini, LM, Bernardi, G, Bono, G, Di Piero, V, Petolicchio, B, Livrea, P, Prudenzano, MP, Pini, LA, Sandrini, G, Allena, M, Tedeschi, G, Russo, A, Caproni, S, Beghi, E & Calabresi, P 2015, 'Psychopathological comorbidities in medication-overuse headache: A multicentre clinical study', European Journal of Neurology, vol. 23, no. 1, pp. 85-91. https://doi.org/10.1111/ene.12794
Sarchielli, P. ; Corbelli, I. ; Messina, P. ; Cupini, L. M. ; Bernardi, G. ; Bono, G. ; Di Piero, V. ; Petolicchio, B. ; Livrea, P. ; Prudenzano, M. P. ; Pini, L. A. ; Sandrini, G. ; Allena, M. ; Tedeschi, G. ; Russo, A. ; Caproni, S. ; Beghi, E. ; Calabresi, P. / Psychopathological comorbidities in medication-overuse headache : A multicentre clinical study. In: European Journal of Neurology. 2015 ; Vol. 23, No. 1. pp. 85-91.
@article{1b192d6a308142cda751c6698020386b,
title = "Psychopathological comorbidities in medication-overuse headache: A multicentre clinical study",
abstract = "Background and purpose: In medication-overuse headache (MOH) patients, the presence of psychopathological disturbances may be a predictor of relapse and poor response to treatment. This multicentre study aimed to assess the occurrence of psychopathological disorders in MOH patients by comparing the incidence of psychopathological disturbances with episodic migraine (EM) patients and healthy controls (HC). Methods: The psychopathological assessment of patients and HC involved the administrations of the Beck Depression Inventory, the Beck Anxiety Inventory, the Modified Mini International Neuropsychiatric Interview (M-MINI), the Yale-Brown Obsessive Compulsive Scale (Y-BOCS) and the Leeds Dependence Questionnaire. Results: The MOH, EM and HC groups (88, 129 and 102 subjects, respectively) differed significantly from each other for the presence of moderate/severe anxiety, whereas mood disorder and depression were revealed in similar proportions for both MOH and EM patients. By stratifying the M-MINI questionnaire results according to the number of psychiatric disorders, it was found that MOH patients had a more complex profile of psychiatric comorbidity. Furthermore, clinically relevant obsessive-compulsive disturbances for abused drugs assessed by Y-BOCS appeared to be more represented in the MOH group, whilst the prevalence of this trait in the EM group was comparable to that of HC (12.5{\%}, 0.8{\%} and 0{\%}, respectively). Conclusions: Our study indicates the multiple presence of psychopathological comorbidities in patients with MOH. In light of this, it is recommended that the assessment of the psychopathological profile be included in an evaluation of MOH patients, allowing the clinician to more rapidly start an appropriate behavioural treatment, which would greatly improve MOH management.",
keywords = "Case-control studies, Headache, Medication-overuse headache, Migraine, Obsessive-compulsive disturbances, Psychiatric disorders",
author = "P. Sarchielli and I. Corbelli and P. Messina and Cupini, {L. M.} and G. Bernardi and G. Bono and {Di Piero}, V. and B. Petolicchio and P. Livrea and Prudenzano, {M. P.} and Pini, {L. A.} and G. Sandrini and M. Allena and G. Tedeschi and A. Russo and S. Caproni and E. Beghi and P. Calabresi",
year = "2015",
month = "7",
day = "31",
doi = "10.1111/ene.12794",
language = "English",
volume = "23",
pages = "85--91",
journal = "European Journal of Neurology",
issn = "1351-5101",
publisher = "Wiley-Blackwell Publishing Ltd",
number = "1",

}

TY - JOUR

T1 - Psychopathological comorbidities in medication-overuse headache

T2 - A multicentre clinical study

AU - Sarchielli, P.

AU - Corbelli, I.

AU - Messina, P.

AU - Cupini, L. M.

AU - Bernardi, G.

AU - Bono, G.

AU - Di Piero, V.

AU - Petolicchio, B.

AU - Livrea, P.

AU - Prudenzano, M. P.

AU - Pini, L. A.

AU - Sandrini, G.

AU - Allena, M.

AU - Tedeschi, G.

AU - Russo, A.

AU - Caproni, S.

AU - Beghi, E.

AU - Calabresi, P.

PY - 2015/7/31

Y1 - 2015/7/31

N2 - Background and purpose: In medication-overuse headache (MOH) patients, the presence of psychopathological disturbances may be a predictor of relapse and poor response to treatment. This multicentre study aimed to assess the occurrence of psychopathological disorders in MOH patients by comparing the incidence of psychopathological disturbances with episodic migraine (EM) patients and healthy controls (HC). Methods: The psychopathological assessment of patients and HC involved the administrations of the Beck Depression Inventory, the Beck Anxiety Inventory, the Modified Mini International Neuropsychiatric Interview (M-MINI), the Yale-Brown Obsessive Compulsive Scale (Y-BOCS) and the Leeds Dependence Questionnaire. Results: The MOH, EM and HC groups (88, 129 and 102 subjects, respectively) differed significantly from each other for the presence of moderate/severe anxiety, whereas mood disorder and depression were revealed in similar proportions for both MOH and EM patients. By stratifying the M-MINI questionnaire results according to the number of psychiatric disorders, it was found that MOH patients had a more complex profile of psychiatric comorbidity. Furthermore, clinically relevant obsessive-compulsive disturbances for abused drugs assessed by Y-BOCS appeared to be more represented in the MOH group, whilst the prevalence of this trait in the EM group was comparable to that of HC (12.5%, 0.8% and 0%, respectively). Conclusions: Our study indicates the multiple presence of psychopathological comorbidities in patients with MOH. In light of this, it is recommended that the assessment of the psychopathological profile be included in an evaluation of MOH patients, allowing the clinician to more rapidly start an appropriate behavioural treatment, which would greatly improve MOH management.

AB - Background and purpose: In medication-overuse headache (MOH) patients, the presence of psychopathological disturbances may be a predictor of relapse and poor response to treatment. This multicentre study aimed to assess the occurrence of psychopathological disorders in MOH patients by comparing the incidence of psychopathological disturbances with episodic migraine (EM) patients and healthy controls (HC). Methods: The psychopathological assessment of patients and HC involved the administrations of the Beck Depression Inventory, the Beck Anxiety Inventory, the Modified Mini International Neuropsychiatric Interview (M-MINI), the Yale-Brown Obsessive Compulsive Scale (Y-BOCS) and the Leeds Dependence Questionnaire. Results: The MOH, EM and HC groups (88, 129 and 102 subjects, respectively) differed significantly from each other for the presence of moderate/severe anxiety, whereas mood disorder and depression were revealed in similar proportions for both MOH and EM patients. By stratifying the M-MINI questionnaire results according to the number of psychiatric disorders, it was found that MOH patients had a more complex profile of psychiatric comorbidity. Furthermore, clinically relevant obsessive-compulsive disturbances for abused drugs assessed by Y-BOCS appeared to be more represented in the MOH group, whilst the prevalence of this trait in the EM group was comparable to that of HC (12.5%, 0.8% and 0%, respectively). Conclusions: Our study indicates the multiple presence of psychopathological comorbidities in patients with MOH. In light of this, it is recommended that the assessment of the psychopathological profile be included in an evaluation of MOH patients, allowing the clinician to more rapidly start an appropriate behavioural treatment, which would greatly improve MOH management.

KW - Case-control studies

KW - Headache

KW - Medication-overuse headache

KW - Migraine

KW - Obsessive-compulsive disturbances

KW - Psychiatric disorders

UR - http://www.scopus.com/inward/record.url?scp=84954570342&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84954570342&partnerID=8YFLogxK

U2 - 10.1111/ene.12794

DO - 10.1111/ene.12794

M3 - Article

VL - 23

SP - 85

EP - 91

JO - European Journal of Neurology

JF - European Journal of Neurology

SN - 1351-5101

IS - 1

ER -